A recent transnational study has determined that daily use of high potency cannabis can increase the risk of developing psychotic disorder.
In this review article from Neurodegenerative Disease Management, discover how Parkinson’s disease psychosis may be optimally diagnosed and managed to improve quality of life.
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoancepahlopathy presenting with postpartum psychosis and late-onset stroke
In this article the authors aims to describe the unusual presentation of a novel family with cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoancepahlopathy.
This article discusses the psychopathology, syndrome definition and assessment tools as linked with DSM-5.
Future Neurology’s special focus on catatonia reviews the nosology, classification, etiology and treatment of the underecognized syndrome.
This editorial explores nonpharmacological treatment options for psychosis in Parkinson’s disease, drawing lessons from pre-existing dementia and schizophrenia literature.
The hippocampo-prefrontal pathway: a possible therapeutic target for negative and cognitive symptoms of schizophrenia
This review discusses the anatomical, physiological and functional characteristics of the rodent hippocampo-prefrontal pathway, which has been linked to cognitive and emotional disturbances in several psychiatric disorders including schizophrenia
This review provides a summary and update on the most recent epigenetic findings, with an emphasis on epigenetic therapeutics in psychotic diseases.